SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-22-010053
Filing Date
2022-04-15
Accepted
2022-04-15 14:12:30
Documents
68
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 2731110
2 ex4-3.htm EX-4.3 18816
3 ex10-144.htm EX-10.144 165680
4 ex10-145.htm EX-10.145 98210
5 ex10-146.htm EX-10.146 137748
6 ex10-147.htm EX-10.147 93550
7 ex21.htm EX-21 2094
8 ex23-1.htm EX-23.1 4999
9 ex31-1.htm EX-31.1 17051
10 ex31-2.htm EX-31.2 17683
11 ex32.htm EX-32 8397
12 form10-k_001.jpg GRAPHIC 14584
  Complete submission text file 0001493152-22-010053.txt   11814199

Data Files

Seq Description Document Type Size
13 XBRL SCHEMA FILE rspi-20211231.xsd EX-101.SCH 78421
14 XBRL CALCULATION FILE rspi-20211231_cal.xml EX-101.CAL 48519
15 XBRL DEFINITION FILE rspi-20211231_def.xml EX-101.DEF 329209
16 XBRL LABEL FILE rspi-20211231_lab.xml EX-101.LAB 582125
17 XBRL PRESENTATION FILE rspi-20211231_pre.xml EX-101.PRE 429551
62 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1931929
Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452
Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947
RespireRx Pharmaceuticals Inc. (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-16467 | Film No.: 22829651
SIC: 2834 Pharmaceutical Preparations